Albireo Pharma
Financial ratios & Valuation

Historical Multiples (2012 – 2021)

2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 TTM Median
Valuation Ratios
Price/Earnings ratio
-1.47-2.54-0.73-1.06-1.34-8.19-6.22-4.40-5.03-2.95-6.61-8.19
Price/Sales ratio
N/AN/AN/AN/A1.93200.17K22.5332.8172.1611.0315.121.93
Price/Book Value ratio
0.981.510.450.500.593.062.343.393.302.548.670.59
Price/Cash Flow ratio
-1.83-2.65-0.55-1.09-2.50-7.26-10.71-5.97-5.93-4.16-4.63-4.63
Price/Free Cash Flow ratio
-1.83-2.64-0.55-1.09-2.50-7.21-10.68-5.91-5.92-4.14-4.59-4.59
Price/Earnings Growth ratio
0.03-0.070.010.030.360.10-0.23-0.09-0.17-0.52-0.080.10
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/A100%100%100%77.06%100%96.65%95.56%100%
Operating Profit Margin
N/AN/AN/AN/A-108.18%-2457700%-297.40%-634.20%-1158.77%-304.30%-214.16%-214.16%
Pretax Profit Margin
N/AN/AN/AN/A-143.32%-2420200%-361.78%-650.86%-1295.53%-83.86%-235.11%-235.11%
Net Profit Margin
N/AN/AN/AN/A-143.87%-2441400%-361.93%-744.12%-1432.29%-372.97%-228.51%-228.51%
Effective Tax Rate
-0.08%-0.07%-0.18%-0.15%-0.38%-0.87%-0.04%-14.32%-10.55%-344.75%2.80%-0.38%
Return on Assets
-50.43%-46.98%-55.57%-45.23%-32.92%-33.34%-24.86%-43.43%-41.66%-50.10%-40.82%-33.34%
Return On Equity
-66.89%-59.37%-61.99%-47.36%-44.24%-37.41%-37.59%-76.96%-65.65%-86.18%-97.58%-37.41%
Return on Capital Employed
-50.31%-53.05%-102.34%-52.43%-33.27%-37.63%-21.94%-41.81%-36.98%-48.10%-43.36%-37.63%
Liquidity Ratios
Current Ratio
14.2216.4115.4122.732.426.9313.077.4910.35N/A6.312.42
Quick Ratio
14.0916.3115.4122.732.426.9313.077.4910.355.925.932.42
Cash ratio
14.0416.2915.2122.592.356.7112.776.969.935.475.882.35
Days of Sales Outstanding
N/AN/AN/AN/A11.88264.99K83.51N/AN/A29.4312.9011.88
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/A52.21451.27N/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/A81.65454.45N/A
Days of Payables Outstanding
N/AN/AN/AN/AN/AN/AN/A790.28N/A1.75K995.97N/A
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/A-790.28N/A-1.67K-871.79N/A
Debt Ratios
Debt Ratio
0.240.20N/AN/A0.06N/AN/AN/A0.030.030.680.06
Debt Equity Ratio
0.32N/AN/AN/A0.08N/AN/AN/A0.050.052.200.08
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/A0.050.05N/AN/A
Total Debt to Capitalization
N/AN/AN/AN/A0.07N/AN/AN/A0.050.05N/AN/A
Interest Coverage Ratio
N/AN/A-393.08-380.13-9.32N/AN/A-11.53-8.47N/A-10.77N/A
Cash Flow to Debt Ratio
N/AN/AN/AN/A-2.85N/AN/AN/A-10.50-10.75N/A-2.85
Company Equity Multiplier
1.321.261.111.041.341.121.511.771.571.723.201.34
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/A-0.77-27.56K-2.10-5.49-12.16-2.65-3.26-3.26
Free Cash Flow / Operating Cash Flow Ratio
1.001.001.0011.001.001.001.011.001.001.011.00
Cash Flow Coverage Ratio
N/AN/AN/AN/A-2.85N/AN/AN/A-10.50-10.75N/A-2.85
Short Term Coverage Ratio
N/AN/AN/AN/A-2.85N/AN/AN/AN/AN/AN/A-2.85
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A